Hayka Hovsepyan, MD Internal Medicine - Geriatric Medicine Medicare: Medicare Enrolled Practice Location: 14901 Rinaldi St Ste 200, Mission Hills, CA 91345 Phone: 818-365-8553 Fax: 818-365-5763 |
News Archive
Akebia Therapeutics, Inc., a pharmaceutical discovery and development company focused on anemia and vascular disorders, today announced that it has successfully completed a randomized, double-blinded, placebo-controlled Phase 2 dose-ranging study of AKB-6548 in patients with stage 3 and 4 chronic kidney disease (CKD).
The holiday season can be a real headache for employers as absenteeism increases as the party season approaches. Everyone looks forward to the parties, social gatherings and family meals as opportunities to abandon self-discipline and enjoy all that the festive season has to offer. Even the most disciplined can end up feeling "under the weather" the morning after and this often leads to a sick day.
Drug resistance remains a major problem in combating HIV infection, but a different approach to drug development could be the answer.Current viral inhibitors target the HIV-1 protease function with a competitive mechanism. Writing in the BJ ChemBio Knowledge Environment of the Biochemical Journal, Max Chang and colleagues from the Scripps Research Institute, La Jolla, suggest that pharmaceutical companies look at compounds that use an allosteric non-competitive mechanism of inhibition.
As President Barack Obama is pilloried for the rocky rollout of the law, the White House struggles with how to refocus the public's attention, since some of the strongest arguments for the law are longer-term benefits that are harder to comprehend.
› Verified 4 days ago